HHV Biotech
PrivateMomentum
Top 25%
of companies Caplight tracks
Company Overview
HHV Biotech is a biotechnology company that develops innovative treatments for biofilm-related infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
HHV Biotech Comparables
Compare HHV Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Disperazol Pharma ApS | 81% | |
| Arivin Therapeutics | 80% | |
| Zaluvida Ventures | 79% |
HHV Biotech Funding Rounds
Historical fundraising activity
HHV Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Surmount Ventures | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 128% MoM, reaching 1.6K.
- Jun 20, 2026
Monthly visitors increased 41% MoM.
HHV Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about HHV Biotech's valuation, stock price, and market status.
Is HHV Biotech a public or private company?
HHV Biotech is a private company.
What is the current stock price of HHV Biotech?
HHV Biotech is a private company with no public stock price. No recent secondary market data is available.
How much is HHV Biotech worth (valuation)?
Valuation information for HHV Biotech is not publicly available.
Can I buy HHV Biotech stock?
HHV Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was HHV Biotech's last funding round?
Funding round information for HHV Biotech is not publicly available.
Who are the main investors in HHV Biotech?
Key investors in HHV Biotech include Surmount Ventures.
Will HHV Biotech IPO soon?
No public IPO plans have been announced for HHV Biotech.
How can I track HHV Biotech secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor HHV Biotech's secondary market activity and sign up for updates.